Literature DB >> 19569969

Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.

Michael J Rybak1, Ben M Lomaestro, John C Rotschafer, Robert C Moellering, Willam A Craig, Marianne Billeter, Joseph R Dalovisio, Donald P Levine.   

Abstract

Practice guidelines for therapeutic monitoring of vancomycin treatment for Staphylococcus aureus infection in adult patients were reviewed by an expert panel of the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. A literature review of existing evidence regarding vancomycin dosing and monitoring of serum concentrations, in addition to patient outcomes combined with expert opinion regarding the drug's pharmacokinetic, pharmacodynamic, and safety record, resulted in new recommendations for targeting and adjustment of vancomycin therapy.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19569969     DOI： 10.1086/600877

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  202 in total

1.  Antimicrobial stewardship.

Authors:  Shira Doron; Lisa E Davidson
Journal:  Mayo Clin Proc       Date:  2011-11       Impact factor: 7.616

2.  Suitability of initial antibiotic therapy for the treatment of bloodstream infections and the potential role of antibiotic management teams in improving it.

Authors:  S Diamantis; C Rioux; C Bonnal; É Farfour; E Papy; A Andremont; P Yeni; É Bouvet; J-C Lucet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-02       Impact factor: 3.267

3.  Pharmacokinetic-pharmacodynamic evaluation of daptomycin, tigecycline, and linezolid versus vancomycin for the treatment of MRSA infections in four western European countries.

Authors:  A Canut; A Isla; C Betriu; A R Gascón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-28       Impact factor: 3.267

Review 4.  Current trends in the management of cardiac implantable electronic device (CIED) infections.

Authors:  Emanuele Durante-Mangoni; Irene Mattucci; Federica Agrusta; Marie-Françoise Tripodi; Riccardo Utili
Journal:  Intern Emerg Med       Date:  2012-06-29       Impact factor: 3.397

5.  Therapeutic drug monitoring of antimicrobials.

Authors:  Jason A Roberts; Ross Norris; David L Paterson; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2012-01       Impact factor: 4.335

6.  Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats.

Authors:  Nathaniel J Rhodes; Walter C Prozialeck; Thomas P Lodise; Natarajan Venkatesan; J Nicholas O'Donnell; Gwendolyn Pais; Cameron Cluff; Peter C Lamar; Michael N Neely; Anil Gulati; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

7.  Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.

Authors:  Kimberly C Claeys; Evan J Zasowski; Anthony M Casapao; Abdalhamid M Lagnf; Jerod L Nagel; Cynthia T Nguyen; Jessica A Hallesy; Mathew T Compton; Keith S Kaye; Donald P Levine; Susan L Davis; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

8.  Factors associated with ceftriaxone nonsusceptibility of Streptococcus pneumoniae: analysis of South African national surveillance data, 2003 to 2010.

Authors:  Claire von Mollendorf; Cheryl Cohen; Linda de Gouveia; Vanessa Quan; Susan Meiring; Charles Feldman; Keith P Klugman; Anne von Gottberg
Journal:  Antimicrob Agents Chemother       Date:  2014-03-31       Impact factor: 5.191

9.  Effect of Vancomycin-Associated Acute Kidney Injury on Incidence of 30-Day Readmissions among Hospitalized Veterans Affairs Patients with Skin and Skin Structure Infections.

Authors:  Nimish Patel; Nicholas Stornelli; Ryan J Sangiovanni; David B Huang; Thomas P Lodise
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

10.  Pulmonary Delivery of Vancomycin Dry Powder Aerosol to Intubated Rabbits.

Authors:  Bradley P Sullivan; Nashwa El-Gendy; Christopher Kuehl; Cory Berkland
Journal:  Mol Pharm       Date:  2015-05-06       Impact factor: 4.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.